We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+3.31%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$43.8B
AUM Growth
+$1B
(+2.3%)
Cap. Flow
-$59.5M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
14.97%
Holding
3,057
New
207
Increased
1,365
Reduced
1,344
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$40.8M |
| 2 |
NXP Semiconductors
NXPI
|
+$30.9M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$26.7M |
| 4 |
Meta Platforms (Facebook)
META
|
+$17M |
| 5 |
Amazon
AMZN
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
YHOO
Yahoo Inc
YHOO
|
+$68.4M |
| 2 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$29.2M |
| 3 |
Apple
AAPL
|
+$23.6M |
| 4 |
WWAV
The WhiteWave Foods Company
WWAV
|
+$20.5M |
| 5 |
VAL
Valspar
VAL
|
+$18.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.4% |
| 2 | Technology | 15.29% |
| 3 | Healthcare | 13.69% |
| 4 | Industrials | 10.84% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICON
2126
DELISTED
Iconix Brand Group, Inc.
ICON
| $721K | ﹤0.01% |
10,435
+528
| +5% | +$35.9K |
|
|
KERX
2127
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $721K | ﹤0.01% |
99,711
+335
| +0.3% | +$2.09K |
|
|
SGBK
2128
DELISTED
Stonegate Bank
SGBK
| $719K | ﹤0.01% |
15,559
+1,466
| +10% | +$67.2K |
|
|
ACHN
2129
DELISTED
Achillion Pharmaceuticals
ACHN
| $718K | ﹤0.01% |
156,416
+14,657
| +10% | +$58.9K |
|
2130
Weis Markets
WMK
$1.92B
| $717K | ﹤0.01% |
14,725
-1,255
| -8% | -$69.2K |
|
|
SPWR
2131
DELISTED
SunPower Corporation Common Stock
SPWR
| $717K | ﹤0.01% |
117,199
+27,683
| +31% | +$136K |
|
|
GOOD
2132
Gladstone Commercial Corp
GOOD
$623M
| $716K | ﹤0.01% |
32,879
+1,365
| +4% | +$29.1K |
|
2133
Future Fuel
FF
$205M
| $712K | ﹤0.01% |
47,172
+288
| +0.6% | +$4.23K |
|
|
KBAL
2134
DELISTED
Kimball International
KBAL
| $712K | ﹤0.01% |
42,663
-700
| -2% | -$12.1K |
|
2135
Babcock & Wilcox
BW
$1.18B
| $711K | ﹤0.01% |
6,042
+262
| +5% | +$27K |
|
2136
PTC Therapeutics
PTCT
$6.18B
| $711K | ﹤0.01% |
38,768
-3,525
| -8% | -$47.5K |
|
|
UCTT
2137
Ultra Clean Holdings
UCTT
$3.12B
| $711K | ﹤0.01% |
37,929
-3,840
| -9% | -$77.3K |
|
|
AKAO
2138
DELISTED
Achaogen Inc
AKAO
| $711K | ﹤0.01% |
+32,724
| New | +$747K |
|
2139
Middlesex Water
MSEX
$1.07B
| $710K | ﹤0.01% |
17,934
-2,080
| -10% | -$77.7K |
|
|
CWEN.A
2140
DELISTED
Clearway Energy Class A
CWEN.A
| $707K | ﹤0.01% |
41,461
-451
| -1% | -$7.72K |
|
2141
Sunrun
RUN
$2.26B
| $705K | ﹤0.01% |
98,976
+32,942
| +50% | +$178K |
|
|
ALDR
2142
DELISTED
Alder Biopharmaceuticals
ALDR
| $703K | ﹤0.01% |
61,416
+4,825
| +9% | +$89.2K |
|
2143
MacroGenics
MGNX
$233M
| $702K | ﹤0.01% |
40,105
+3,755
| +10% | +$71.6K |
|
|
PSTB
2144
DELISTED
Park Sterling Corp.
PSTB
| $702K | ﹤0.01% |
59,064
-4,904
| -8% | -$58.4K |
|
2145
Heron Therapeutics
HRTX
$93.4M
| $701K | ﹤0.01% |
50,630
+6,249
| +14% | +$90.5K |
|
|
IMGN
2146
DELISTED
Immunogen Inc
IMGN
| $698K | ﹤0.01% |
98,176
-3,767
| -4% | -$17.2K |
|
|
INST
2147
DELISTED
Instructure, Inc.
INST
| $694K | ﹤0.01% |
23,532
+12,805
| +119% | +$326K |
|
|
FLXN
2148
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $693K | ﹤0.01% |
34,283
+80
| +0.2% | +$1.67K |
|
|
FMSA
2149
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $692K | ﹤0.01% |
177,544
+64,314
| +57% | +$333K |
|
|
SP
2150
DELISTED
SP Plus Corporation
SP
| $691K | ﹤0.01% |
22,617
+20
| +0.1% | +$622 |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2017 Portfolio in Review
As of Q2 2017, RhumbLine Advisers held 3,057 positions worth $43.8B, up 2.3% from $42.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers's Q2 2017 filing shows 207 new, 1,365 increased, 1,344 reduced and 128 closed positions. Its largest new stake was DXC Technology: 615,360 shares worth $40.8M. The largest sale was Yahoo Inc, an estimated $68.4M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q2 2017 buy was DXC Technology: 615,360 shares worth $40.8M.
- RhumbLine Advisers added most to IHS Markit Ltd. Common Shares in Q2 2017, an estimated $26.7M increase.
- RhumbLine Advisers's biggest Q2 2017 reduction was Apple, cutting an estimated $23.6M.
- RhumbLine Advisers fully exited Yahoo Inc in Q2 2017, selling an estimated $68.4M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $43.8B portfolio in Q2 2017.
- RhumbLine Advisers opened 207 new positions and closed 128 in Q2 2017.
- RhumbLine Advisers's portfolio value rose 2.3% quarter-over-quarter to $43.8B.
Based on RhumbLine Advisers's 13F filing for Q2 2017, filed 2 Aug 2017.